CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong · Delayed Price · Currency is HKD 7.48
-0.10 (-1.32%)
May 19, 2026, 11:59 AM HKT
CSPC Pharmaceutical Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 3,882 | 4,328 | 5,873 | 6,091 | 5,605 |
Depreciation & Amortization | 1,320 | 1,249 | 1,083 | 1,004 | 862.38 |
Other Amortization | 92.27 | 90.65 | 34.94 | 43.45 | 3.1 |
Loss (Gain) From Sale of Assets | 16.47 | 23.4 | 22.23 | 7.36 | 10.79 |
Asset Writedown & Restructuring Costs | - | 0.18 | 42.32 | 72.11 | 50 |
Loss (Gain) From Sale of Investments | -286.29 | 151.94 | 177.85 | -148.97 | -242.41 |
Loss (Gain) on Equity Investments | 52.45 | 89.47 | 54.2 | 15.4 | -22.44 |
Stock-Based Compensation | -65.95 | 210.45 | 235.09 | 160.73 | 17.73 |
Provision & Write-off of Bad Debts | -9.97 | 16.3 | 18.41 | -25.73 | 4.07 |
Other Operating Activities | -308 | -807.3 | -330.26 | -391.27 | -263.85 |
Change in Accounts Receivable | 391.78 | 692.25 | -1,973 | -566.55 | -943.55 |
Change in Inventory | 42.03 | 8.65 | -583.75 | -42.75 | -617.07 |
Change in Accounts Payable | 654.76 | -758.87 | 918.13 | 18.45 | 276.79 |
Change in Unearned Revenue | 1,366 | 135.12 | -275.07 | 468.63 | -44.22 |
Change in Other Net Operating Assets | -1,317 | -894.41 | -1,118 | 920.34 | -59.87 |
Operating Cash Flow | 5,832 | 4,535 | 4,179 | 7,627 | 4,637 |
Operating Cash Flow Growth | 28.60% | 8.52% | -45.21% | 64.50% | -31.20% |
Capital Expenditures | -1,959 | -2,015 | -1,624 | -2,220 | -1,410 |
Sale of Property, Plant & Equipment | 0.16 | 99.92 | 139.99 | 16.83 | 85.69 |
Cash Acquisitions | - | - | - | -341.91 | -24.35 |
Divestitures | - | - | - | - | 150.91 |
Sale (Purchase) of Intangibles | -320.25 | -560.08 | -265.43 | -484.54 | -339.15 |
Investment in Securities | -2,080 | -1,615 | 2,171 | -4,075 | 630.71 |
Other Investing Activities | 481.75 | 232.62 | 443.5 | 308.74 | 269.01 |
Investing Cash Flow | -3,878 | -3,858 | 865.86 | -6,796 | -637.33 |
Long-Term Debt Issued | 21 | 28 | - | 485.71 | - |
Total Debt Issued | 21 | 28 | - | 485.71 | - |
Long-Term Debt Repaid | -166.88 | -152.36 | -166.43 | -620.95 | -222.17 |
Total Debt Repaid | -166.88 | -152.36 | -166.43 | -620.95 | -222.17 |
Net Debt Issued (Repaid) | -145.88 | -124.36 | -166.43 | -135.24 | -222.17 |
Issuance of Common Stock | 22.88 | 106.43 | - | - | - |
Repurchase of Common Stock | -418.45 | -2,196 | -458.95 | -14.21 | -263.51 |
Common Dividends Paid | -2,497 | -3,234 | -2,726 | -2,097 | -1,691 |
Other Financing Activities | 427.11 | 194 | 792.06 | 342.34 | -20.16 |
Financing Cash Flow | -2,612 | -5,253 | -2,560 | -1,904 | -2,197 |
Foreign Exchange Rate Adjustments | -4.81 | 3.4 | 4.89 | 14.14 | -2.44 |
Net Cash Flow | -662.88 | -4,573 | 2,490 | -1,059 | 1,800 |
Free Cash Flow | 3,872 | 2,519 | 2,555 | 5,407 | 3,226 |
Free Cash Flow Growth | 53.70% | -1.40% | -52.74% | 67.58% | -40.07% |
Free Cash Flow Margin | 14.89% | 8.69% | 8.12% | 17.48% | 11.58% |
Free Cash Flow Per Share | 0.34 | 0.21 | 0.21 | 0.45 | 0.27 |
Cash Interest Paid | 10.97 | 7.65 | 15.99 | 21.54 | 7.66 |
Cash Income Tax Paid | 824.44 | 1,693 | 1,309 | 1,335 | 1,141 |
Levered Free Cash Flow | 2,926 | 2,130 | 1,164 | 3,826 | 1,721 |
Unlevered Free Cash Flow | 2,951 | 2,158 | 1,180 | 3,841 | 1,726 |
Change in Working Capital | 1,138 | -817.26 | -3,032 | 798.12 | -1,388 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.